{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:18:31Z","timestamp":1791065911748,"version":"4.1.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T00:00:00Z","timestamp":1369008000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0064314","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T21:01:19Z","timestamp":1369083679000},"page":"e64314","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation"],"prefix":"10.1371","volume":"8","author":[{"given":"Richard J.","family":"Perrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline E.","family":"Payton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Reid","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer&apos;s disease: the challenge of the second century","volume":"3","author":"DM Holtzman","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: A novel prognostic fluid biomarker for preclinical Alzheimer&apos;s disease","volume":"68","author":"R Craig-Schapiro","year":"2010","journal-title":"Biol Psychiatry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/A\u03b242 ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"A Fagan","year":"2007","journal-title":"Arch Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","article-title":"CSF tau\/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study","volume":"69","author":"G Li","year":"2007","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","article-title":"Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","volume":"66","author":"JC Morris","year":"2009","journal-title":"Arch Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.58.9.1395","article-title":"Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer&apos;s disease","volume":"58","author":"J Price","year":"2001","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer&apos;s disease","volume":"16","author":"T Gomez-Isla","year":"1996","journal-title":"J Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer&apos;s disease","volume":"461","author":"RJ Perrin","year":"2009","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer&apos;s pathological cascade","volume":"9","author":"CR Jack Jr","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and CSF Ab42 in humans","volume":"59","author":"A Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"AM Fagan","year":"2009","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer&apos;s disease","volume":"1","author":"AM Fagan","year":"2009","journal-title":"EMBO Mol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2967\/jnumed.109.064360","article-title":"Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding","volume":"50","author":"N Tolboom","year":"2009","journal-title":"J Nucl Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2009.01.027","article-title":"Beta amyloid in Alzheimer&apos;s disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid","volume":"65","author":"T Grimmer","year":"2009","journal-title":"Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000280577.43413.d9","article-title":"Trajectories of brain loss in aging and the development of cognitive impairment","volume":"70","author":"NE Carlson","year":"2008","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose\/poitron-emission tomography (FDG\/PET)","volume":"98","author":"MJ de Leon","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","article-title":"Mild cognitive impairment - Can FDG-PET predict who is to rapidly convert to Alzheimer&apos;s disease","volume":"60","author":"G Chetelat","year":"2003","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e18850","DOI":"10.1371\/journal.pone.0018850","article-title":"Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer&apos;s disease diagnosis and prognosis","volume":"6","author":"R Craig-Schapiro","year":"2011","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1212\/WNL.0b013e318248e568","article-title":"CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease","volume":"78","author":"R Tarawneh","year":"2012","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e16032","DOI":"10.1371\/journal.pone.0016032","article-title":"Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer&apos;s disease","volume":"6","author":"RJ Perrin","year":"2011","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.21623","article-title":"A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system","volume":"66","author":"RJ Bateman","year":"2009","journal-title":"Ann Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00001756-200204160-00015","article-title":"Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients","volume":"13","author":"P Davidsson","year":"2002","journal-title":"Neuroreport"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/1522-2683(200207)23:14<2247::AID-ELPS2247>3.0.CO;2-M","article-title":"Studies of potential cerebrospinal fluid molecular markers for Alzheimer&apos;s disease","volume":"23","author":"L Choe","year":"2002","journal-title":"Electrophoresis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","article-title":"Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer&apos;s disease","volume":"118","author":"M Puchades","year":"2003","journal-title":"Mol Brain Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5956-2-7","article-title":"Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients","volume":"2","author":"SF Hansson","year":"2004","journal-title":"Proteome Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1179\/016164106X98035","article-title":"Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer&apos;s disease and non-demented elderly subjects","volume":"28","author":"E Castano","year":"2006","journal-title":"Neurol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.21038","article-title":"Cerebrospinal fluid proteomic biomarkers for Alzheimer&apos;s disease","volume":"61","author":"E Finehout","year":"2006","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.21038","article-title":"Cerebrospinal fluid proteomic biomarkers for Alzheimer&apos;s disease","volume":"61","author":"EJ Finehout","year":"2007","journal-title":"Ann Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1074\/mcp.M500207-MCP200","article-title":"Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid","volume":"4","author":"Y Hu","year":"2005","journal-title":"Mol & Cell Proteom"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/prca.200600999","article-title":"Identification and validation of novel CSF biomarkers for early stages of Alzheimer&apos;s disease","volume":"1","author":"Y Hu","year":"2007","journal-title":"Proteomics - Clin Appl"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/pmic.200300470","article-title":"A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer&apos;s disease","volume":"3","author":"O Carrette","year":"2003","journal-title":"Proteomics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1471-4159.2005.03478.x","article-title":"Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis","volume":"95","author":"S Ranganathan","year":"2005","journal-title":"J Neurochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000110576","article-title":"A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer&apos;s disease versus normal aging and frontotemporal dementia","volume":"24","author":"AH Simonsen","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archneur.64.3.366","article-title":"Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment","volume":"64","author":"AH Simonsen","year":"2007","journal-title":"Arch Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/pmic.200700446","article-title":"Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry","volume":"8","author":"MP Stoop","year":"2008","journal-title":"Proteomics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2005-7205","article-title":"Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease","volume":"7","author":"J Zhang","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1021\/ac702422x","article-title":"Relative quantification of proteins in human cerebrospinal fluids by MS\/MS using 6-plex isobaric tags","volume":"80","author":"L Dayon","year":"2008","journal-title":"Anal Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/pmic.200700455","article-title":"Differential protein expression in male and female human lumbar cerebrospinal fluid using iTRAQ reagents after abundant protein depletion","volume":"7","author":"Y Ogata","year":"2007","journal-title":"Proteomics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/pmic.200700316","article-title":"8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer&apos;s disease","volume":"7","author":"LDAM Choe","year":"2007","journal-title":"Proteomics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/pr100532g","article-title":"Evolution of clinical proteomics and its role in medicine","volume":"10","author":"E Boja","year":"2011","journal-title":"J Proteome Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/jms.1692","article-title":"Current trends in quantitative proteomics","volume":"44","author":"MH Elliott","year":"2009","journal-title":"J Mass Spectrom"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jasms.2004.04.034","article-title":"Charge competition and the linear dynamic range of detection in electrospray ionization mass spectrometry","volume":"15","author":"K Tang","year":"2004","journal-title":"J Am Soc Mass Spectrom"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/pr050406g","article-title":"Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: Reproducibility, linearity, and application with complex proteomes","volume":"5","author":"G Wang","year":"2006","journal-title":"J Proteome Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1152\/physiolgenomics.00298.2007","article-title":"Data analysis and bioinformatics tools for tandem mass spectrometry in proteomics","volume":"33","author":"EW Deutsch","year":"2008","journal-title":"Physiol Genomics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/mas.20071","article-title":"Advances in proteomics data analysis and display using an accurate mass and time tag approach","volume":"25","author":"JS Zimmer","year":"2006","journal-title":"Mass Spectrom Rev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer&apos;s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer&apos;s Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of b-amyloid peptide<sub>42<\/sub> in the cerebrospinal fluid of patients with Alzheimer&apos;s disease","volume":"38","author":"R Motter","year":"1995","journal-title":"Ann Neurol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased b-amyloid<sub>1\u201342<\/sub> and increased tau levels in cerebrospinal fluid of patients with Alzheimer&apos;s disease","volume":"289","author":"T Sunderland","year":"2003","journal-title":"JAMA"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/01.wnl.0000228231.26111.6e","article-title":"Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI","volume":"67","author":"M Storandt","year":"2006","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1399-3046.2009.01205.x","article-title":"Hypertension after pediatric cardiac transplantation: detection, etiology, implications and management","volume":"14","author":"SL Roche","year":"2010","journal-title":"Pediatr Transplant"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"A Keller","year":"2002","journal-title":"Anal Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/pmic.200900437","article-title":"Scaffold: A bioinformatic tool for validating MS\/MS-based proteomic studies","volume":"10","author":"BC Searle","year":"2010","journal-title":"Proteomics"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/bioinformatics\/btn217","article-title":"DAnTE: a statistical tool for quantitative analysis of -omics data","volume":"24","author":"AD Polpitiya","year":"2008","journal-title":"Bioinformatics"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/bioinformatics\/btp362","article-title":"A statistical framework for protein quantitation in bottom-up MS-based proteomics","volume":"25","author":"Y Karpievitch","year":"2009","journal-title":"Bioinformatics"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1021\/pr700705u","article-title":"Label-free detection of differential protein expression by LC\/MALDI mass spectrometry","volume":"7","author":"H Neubert","year":"2008","journal-title":"J Proteome Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e10980","DOI":"10.1371\/journal.pone.0010980","article-title":"Establishing the proteome of normal human cerebrospinal fluid","volume":"5","author":"SE Schutzer","year":"2010","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e17287","DOI":"10.1371\/journal.pone.0017287","article-title":"Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome","volume":"6","author":"SE Schutzer","year":"2011","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-010-0667-0","article-title":"Novel CSF biomarkers for Alzheimer&apos;s disease and mild cognitive impairment","volume":"119","author":"WT Hu","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"F Abdi","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JAD-2011-111505","article-title":"Identification of SPARC-like protein as part of a biomarker panel for Alzheimer&apos;s disease in cerebrospinal fluid","volume":"28","author":"B Vafadar-Isfahani","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/bmm.12.42","article-title":"Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer&apos;s disease","volume":"6","author":"AM Fagan","year":"2012","journal-title":"Biomarkers Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"DN Perkins","year":"1999","journal-title":"Electrophoresis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0064314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T22:30:35Z","timestamp":1715380235000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0064314"}},"subtitle":[],"editor":[{"given":"Dulce Elena","family":"Casarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,20]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0064314","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,20]]}}}